Author

J. A. Ligibel

Observed name: J. Ligibel

Institution: Dana-Farber Cancer Institute

Observed institution: Dana-Farber Cancer Institute

OpenAlex ID: A5126217052

Abstract PS5-09-01: The TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients (THRIVE-65) Trial

2026 · E. Schleicher, J. Oppenheim, et al. · Clinical Cancer Research

Abstract PS1-01-12: Preventing Chemotherapy-Induced Peripheral Neuropathy with Acupuncture: Preliminary Results of a Pooled Analysis of Three Parallel Randomized Trials

2026 · W. Lu, A. Giobbie-Hurder, et al. · Clinical Cancer Research

Abstract PD8-01: Weight Trajectories in the Breast Cancer Weight Loss (BWEL) Trial (Alliance)

2026 · C. Cao, K. Ballman, et al. · Clinical Cancer Research

Abstract PS3-01-30: Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32

2026 · M. Wood, M. I. Elsaid, et al. · Clinical Cancer Research

Abstract PS4-09-29: Variation in weight loss and intervention engagement in the Breast Cancer Weight Loss (BWEL) trial by language and ethnicity (Alliance)

2026 · A. Odai-Afotey, K. V. Ballman, et al. · Clinical Cancer Research

Works count: 5

Citation count:

H-index:

I10-index: